Paper6131739
Immunohistochemical and electron microscopic assessment of childhood rhabdomyosarcoma. Increased frequency of diagnosis over routine histologic methods.
Kahn HJ and 7 others. Cancer, 1983. Cited by 85 papers, by iCite.
Cite this record
ConductScience Library. Immunohistochemical and electron microscopic assessment of childhood rhabdomyosarcoma. Increased frequency of diagnosis over routine histologic methods. Papers, record 6131739. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6131739
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Immunohistochemical and electron microscopic assessment of childhood rhabdomyosarcoma. Increased frequency of diagnosis over routine histologic methods.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Calcium-Transporting ATPases | Major topic |
| Calsequestrin | Major topic |
| Creatine Kinase | Major topic |
| Intermediate Filament Proteins | Major topic |
| Muscle Proteins | Major topic |
| Myoglobin | Major topic |
| Rhabdomyosarcoma | Major topic |
| Ca(2+) Mg(2+)-ATPase | |
| Child | |
| Desmin | |
| Humans | |
| Immunoenzyme Techniques | |
| Isoenzymes | |
| Microscopy, Electron |
Source PubMed
Cited by18
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 85 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41899494 | Biological Advances and Current Challenges for Pediatric Rhabdomyosarcoma. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/41899494 | PubMed |
| 39495123 | ASAP1 and ARF1 Regulate Myogenic Differentiation in Rhabdomyosarcoma by Modulating TAZ Activity. | Mol Cancer Res | 2025 | https://conductscience.org/library/papers/39495123 | PubMed |
| 39060228 | Single cell transcriptomic profiling identifies tumor-acquired and therapy-resistant cell states in pediatric rhabdomyosarcoma. | Nat Commun | 2024 | https://conductscience.org/library/papers/39060228 | PubMed |
| 35483358 | The myogenesis program drives clonal selection and drug resistance in rhabdomyosarcoma. | Dev Cell | 2022 | https://conductscience.org/library/papers/35483358 | PubMed |
| 25197361 | Spindle cell rhabdomyosarcoma of the retroperitoneum: an unusual case developed in a pregnant woman but obscured by pregnancy. | Int J Clin Exp Pathol | 2014 | https://conductscience.org/library/papers/25197361 | PubMed |
| 23450454 | Soft tissue tumors of the anorectum: rare, complex and misunderstood. | J Gastrointest Oncol | 2013 | https://conductscience.org/library/papers/23450454 | PubMed |
| 22144838 | Rhabdomyosarcoma of mandible: A diagnostic predicament. | J Oral Maxillofac Pathol | 2011 | https://conductscience.org/library/papers/22144838 | PubMed |
| 12783965 | Myogenin and MyoD1 expression in paediatric rhabdomyosarcomas. | J Clin Pathol | 2003 | https://conductscience.org/library/papers/12783965 | PubMed |
| 9685856 | Characterization of a new human embryonal rhabdomyosarcoma cell line, RMS-GR. | Jpn J Cancer Res | 1998 | https://conductscience.org/library/papers/9685856 | PubMed |
| 8236815 | Calcium pump expression in human bone and soft tissue tumours. | Virchows Arch A Pathol Anat Histopathol | 1993 | https://conductscience.org/library/papers/8236815 | PubMed |
| 6381545 | An investigation of beta enolase as a histological marker of rhabdomyosarcoma. | J Clin Pathol | 1984 | https://conductscience.org/library/papers/6381545 | PubMed |
| 6209246 | The value of immunohistochemistry in increasing diagnostic precision of undifferentiated tumours by the surgical pathologist. | Histochem J | 1984 | https://conductscience.org/library/papers/6209246 | PubMed |
| 3905869 | Comparison of beta enolase and myoglobin as histological markers of rhabdomyosarcoma. | J Clin Pathol | 1985 | https://conductscience.org/library/papers/3905869 | PubMed |
| 3881039 | Desmin is a specific marker for rhabdomyosarcomas of human and rat origin. | Am J Pathol | 1985 | https://conductscience.org/library/papers/3881039 | PubMed |
| 3354641 | Diagnosis of rhabdomyosarcomas with HHF35, a monoclonal antibody directed against muscle actins. | Am J Pathol | 1988 | https://conductscience.org/library/papers/3354641 | PubMed |
| 3311112 | Evaluation of desmin as a diagnostic and prognostic marker of childhood rhabdomyosarcomas and embryonal sarcomas. | Br J Cancer | 1987 | https://conductscience.org/library/papers/3311112 | PubMed |
| 2757915 | Myoglobin: an evaluation of its role as a marker of rhabdomyosarcomas. | Br J Cancer | 1989 | https://conductscience.org/library/papers/2757915 | PubMed |
| 2653737 | The changing face of hepatic resection. | Curr Probl Surg | 1989 | https://conductscience.org/library/papers/2653737 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| DES | 1674 | PubTator's text mining | https://conductscience.org/library/genes/1674 | NCBI Gene |
| MB | 4151 | PubTator's text mining | https://conductscience.org/library/genes/4151 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6131739
GET https://conductscience.org/api/papers/v1/6131739/authors